Researchers have found a cancer pathway that appears to be common in multiple different types of cancers and are targeting it in treatments. In an article from ScienceDaily, the researchers have found that mutations in the PIK3CA gene cause for an early switch to being a cancer cell due to it signaling for a mutated p110α protein. This finding is important due to the fact that scientists can create treatments that disrupt this mutant cancer pathway, which is what these researchers have done.



This has led to promising treatment results and hopefully less toxic cancer treatment for any type of cancer. The ultimate goal of these findings is to be able to personalize cancer treatment to an individual’s needs. This research is very interesting and hopefully leads to the discovery of the many new treatments these researchers hypothesize could be made available.